Related Experiment Video
Updated: Aug 9, 2026
13:32
High Content Screening in Neurodegenerative Diseases
Published on: January 6, 2012
Finding the needle in the haystack: why high-throughput screening is good for your health
G Wynne Aherne1, Edward McDonald, Paul Workman
1Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, UK.
Breast Cancer Research : BCR
|July 9, 2002
Summary
High-throughput screening accelerates cancer drug development by identifying new molecular targets and compound starting points. This approach is crucial for discovering novel therapeutics for breast cancer and other malignancies.
Area of Science:
- Oncology
- Pharmacology
- Genomics
Background:
- High-throughput screening (HTS) is vital for modern cancer drug development, enhancing speed and efficiency.
- Leveraging new molecular targets from the Human Genome Project and cancer genomics is critical for therapeutic advancement.
- Screening diverse compound libraries provides essential starting points for medicinal chemistry optimization.
Discussion:
- HTS enables the rapid evaluation of numerous compounds against biological targets.
- The integration of genomic data guides the selection of targets for HTS campaigns.
- Medicinal chemistry programs utilize HTS outputs for iterative drug design and refinement.
Key Insights:
- Successful drug discovery programs demonstrate the efficacy of HTS in oncology.
- HTS facilitates the identification of novel therapeutic agents for challenging diseases.
- The synergy between genomics and HTS accelerates the translation of research into clinical applications.
Outlook:
- Future cancer drug development will increasingly rely on advanced screening technologies.
- Personalized medicine approaches will benefit from HTS-driven identification of targeted therapies.
- Continued innovation in HTS methodologies will expand its application in discovering treatments for various cancers.
Related Concept Videos
02:46Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...